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1. Introduction 
Low back pain (LBP) is one of most prevalent and controversial diseases for clinical 
management by multiple factors: resistance of practitioners to the application of the 
knowledge based on scientific evidence, limited use of reliable information, excessive and 
costly radiologic prescriptions either tendency to apply "innovative" technologies and, in 
some cases, to satisfy wishes patients (Cabana MD, 1999).  
There is great variability in medical practice, even within developed countries, which can 
worsen the outcome of the treatment, unjustifiably increase the risk of iatrogenic, and 
needlessly increase healthcare costs. 
So guidelines are needed to reduce it; clinical practice is defined as: "assertions developed 
systematically for help to the doctor and the patient to make decisions appropriate in 
clinical and specific circumstances” (Field MJ & Lohr KN, 1990).  
If further complemented by analysis of cost effectiveness, they adapt to local differences, 
provide for improvement quality systems, are revised and can be summarized and 
disseminated by various means, we will largely achieve the desired goal. 
This chapter aims to disseminate knowledge contrasted on the management of low back pain 
based on scientific evidence and assist medical personnel in key facets as "Critical analysis", 
"Evidence-based medicine" “Design of working groups” and “Clinical trials methodology" for 
the elaboration of a multidisciplinary and improved clinical practice guideline. 
2. Costs and scientific evidence of low back pain  
In developed countries the prevalence is estimated between 12-33%, In the USA the annual 
amount are beetwen 22-65% and the 5th most common cause of doctor visits. (Deyo RA, 
2006). A quarter of adults reported a duration of episode of at least one week. (Carey 
TS,1996). 
The costs generated are high, medical treatment is estimated between 9000 and 19000 $ per 
patient per year, and interventions around 19000 (Straus BN, 2002). Approximately 5% of 
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the population with disability, generates 75% of healthcare costs for low back pain 
(Frymoyer JW, 1991).  
Those who attend care doctor however achieve rapid intensity improvements of pain (58%), 
disability (58%) and ease returning to work (2%) (Pengel LHM, 2003). But relapses are very 
frequent, 60-75% of patients may present at least one of year (Gatchel RJ, 1995). 
On the other hand there are many options for evaluation and treatment of back pain, but 
little consensus regarding the appropriate use if diagnostic and treatment media, excessive 
variation for example indication of surgery, in USA is five times higher than Europe 
(Cherkin DC, 1994). Few technologies have often proved or ineffective and even damaging, 
some based on studies with few benefits. 
There was an increase of 235% between 1997-2006 interventionist techniques in USA 
between 2002-2006 increased to 22%, this growth was parallel to a rise in the prevalence of 
pain due to an improvement of diagnostic means, and progress new injection techniques 
guided by fluoroscopy. Lifetime prevalence of spinal pain was 54-80% (Walker BF, 2000). 
There are significant geographic variations, duration and chronicity also disputes, 90% of 
attacks are resolved in 6 weeks, 5-10% of patients develop persistent pain, however despite 
believing that there will be more episodes, are frequent relapses (4-10%) (Nachemson A, 
2000). 
The “Eurobarometer” 2003-2007 analiyze various aspects of European citizens health, is a 
part of the European Commission Health Strategy. Musculoskeletal problems (bone, 
muscles and joints) affects 22 per cent population, a third of respondents (32%) had 
experienced some pain week prior to the survey. Pain most common type was low 
back,affects 67 million Europeans, became apparent factors demographic. The 55 age group 
are the most likely to say they experienced restrictive pain (44%) (Special Eurobarometer, 
2007). 
Each year one in five adults have low back pain, (Cassidy JD, 2005) to the silent suffering 
back is the second location more frequent of pain (Watkins et al., 2006). However 5-15% of 
acute cases with an established cause should be identified, chronic pain lasts more than 3 
months and affects 10% of cases with high annual costs to 100-200 billion $ (Katz JN, 2006). 
Few documents provide advantages or outcomes assessment, and the first international 
guide for prevention and management of chronic cases was published 2006 (Airaksinen O, 
et al. 2006). 
Low back pain is the most common cause and orthopedic, industrial, face of disability of 
workers under 45. Those who have medical care 25-40% have radiated pain and only 2% 
have strong findings of good surgical results forecasts for the nerve root decompression 
(Saal JA et al., 1990). 
Those with signs of disk herniation, one in half recover a suitable tolerance of daily activities 
so dismiss the surgery. 
Back is one of the most frequently reasons for primary care visit (Saal JA, 1990), sciatica 
slows recovery and is considered announcement of a significant loss of tolerance to 
activities. There is a significant cultural influence on disability appreciation, 20% of Swedes 
who deny having had problems with his back causing disability, continue the work during 
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episodes, have been visited and treated, and many of them being farmers on their own (Blau 
Jn. & Logue V, 1978). 
In Europe lifetime prevalence reaches 59% (Veerle Hermans, 2000), in working population 
with up to 85% recurrence (The bone and joint decade Report 2005). 
The peril of LBP at work affect more frequently to the agriculture, fisheries, and 
construction. The most common body location is the back (Eurobarometer 2007) (Figure 1)  
 
                                                                           
Fig. 1. Special Eurobarometer 272e/Wave 66.2 requested by Directorate General SANCO of 
European Commission 2003-2007 
2.2 Scientific evidence 
Annual scientific production is estimated to be close to 900,000 publications, which nearly 
40000 are medical. Exponential growth since 1970, thanks to the development of basic 
sciences such as mathematics, statistical analysis, computer engineering, the epidemiology 
and biology amongst others.  
The number of systematic reviews and Meta-analysis in Biomedical Sciences published per 
year, is high and increasing, only in English reaches the 2,500. Despite the efforts made with 
certain "resources" and "Declarations" that contemplate later, studies show deficiencies in 
quality and few demonstrate impact of improvement initiatives or inclusion on editorial 
criteria (Moher D the al., 2007). 
Try to standardize clinic practices through diagnostic and therapeutic "protocols" that 
contemplated management diagrams but were due more to a development consensus and 
panels of experts; that is why a group of epidemiologists from Mc Master University 
Locations of pain restricting activity 
Head 6 % 
 
Neck / Shoulder 7 % 
 
 
Low back 11 % 
 
 
Knees 8% 
 
 
Ankle/Foot 5 % 
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(Sackett) published a series of articles on "how to interpret the publications", especially those 
of a clinical and experimental nature. 
Born in 1980s, Canadian Medical Association Journal by proposing term "critical appraisal" 
to describe application of basic rules that allow to find evidence in scientific literature, 
converted by Sackett in "appreciation criticism in header of patient", to extend clinical 
practice. 
In 90´s Guyatt coined term "evidence-based medicine" which should apply from University 
education to clinical practice, to provide efficiency and effectiveness in clinical events and 
individualized way (Guyatt GH, Renie D, 1991). Emerging entities as Collaboration 
Cochrane made systematic revisions of scientific literature by extracting truly relevant 
studies through Meta-analysis and promoting the edition of clinical practice guidelines 
based on scientific evidence (www.cochrane.org).  
Due to variability of medical practice, not consistent with scientific evidence, and profusion 
of scientific literature with poor quality, emerging entities as CONSORT (1994) which are 
intended to implement the quality of work and scientific tests in health area. Through global 
outreach programs that use internet resources developed during the past 25 years 
(www.consort-statement.org ). 
2.3 Health economics 
Health systems in the West have been developped and consolidated with the hospital 
network, organization of primary care which began to generate significant economic costs, 
the European Community adopted a common policy called "System of Social Welfare" 
which provided for the right to universal and State health care whose costs are loaded to 
state budgets and they did recover through taxes fairly distinct. Soon will detect need for 
implementation principles of Economics. Comes the concept of “Clinical Governance” 
Within this trend, large companies and institutions begin became interested in the policies 
of containment of costs and including derivatives of industrial casualties (Spengler D, 1986) 
and the financial outlay to cover the fees of workers and medical care costs (Frymoyer J, 
1991).  
So develop epidemiological research on diseases most prevalent in the industry (Bergquist-
Ullman M, 1977) in parallel with studies of Biomechanics and ergonomics, with adoption of 
measures of legislation to limit the burden on labour and improve the productivity and cost. 
In 1991 Deyo RA publishes one research and collaborators which examines all aspects 
related to low back pain and its impact labor, health, economic and social system is entering 
a crisis. 
First Clinical Practice Guidelines (CPG) were developed in order to manage more prevalent 
diseases; in 1994 the Agency for Health Care Policy Research published the “CPG for 
management of acute low back pain in adults" based on consensus (Bigos S, 1994). 
Subsequently they adapt and develop guides aimed at acute low back pain as “Committee 
on health of New Zealand” (New Zealand acute low back pain guide 1997) which analyses 
risk factors for long-term disability and work loss. Improvement of aspects such as 
diagnosis and treatment as the case of the Guide to Australasia (Bogduk N, 1999). 
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In Europe from population-based studies on low back pain (Biering Sorensen f., 1983), 
National cost-effectiveness in Netherlands (Van Tulder MW, 1995) and systematized the 
Cochrane Cochrane Collaboration reviews, of clinical practice guidelines amounts a step, 
based on scientific evidence and cost-effectiveness. Articulate local adaptations for all 
national health systems in European Union, be revised and therefore adaptable to further 
scientific evidence.  
The COST B13 Guide is pan-European, multidisciplinary, based on scientific evidence, 
publicly funded without participation of the industry or profit institutions. It provides for 
comprehensive management of acute, chronic low back pain and its prevention (Van Tulder 
MW, 2002). In the Spanish adaptation recommendations relating to acute and chronic low 
back pain were merged into a single temporal sequence, in order to improve clinical practice 
application, ordering implementation of technologies recommended depending on type of 
patients and scientific evidence, efficacy, effectiveness and efficiency, and safety (Latorre E 
2008). Added a declaration of conflicts of interest of its members, and followed the 
collaboration criteria AGREE applying this instrument to improve quality 
(www.agreecollaboration.org ). 
3. Which is Low Back Pain (LBP)? 
3.1 Concept and types 
In general, Low back pain is "the pain between the costal margins and the inferior gluteal 
folds, it is influenced by physical activities and postures, accompanied by painful limitation 
of motion, frequently associated with referred pain".  
"Common Low Back Pain is not related to fractures, ankylosis, direct trauma or systemic 
conditions" (or “Non-Specific”). 
Specific low back pain is related to specific pathologies and can be diagnosed early through 
warning signs (Neoplasm, Infectious,vascular,metabolic,or endocrine related) (Wipf & Deyo 
RA, 1995). 
The distribution of the cause of LBP are by frequency: Common low back pain 90%, 
symptomatic herniated disk 3-4%, ankylosis 0.3 - 5%, compression fractures 4%, and spinal 
malignancy 0.7% (Van Tulder, 2006). 
Pain can occur in different ways: 
Episodes acute last less than 3 months in more than 90% of the cases, which are usually 
benign, and they can be treated with simple steps, usually this corresponds to the type "Non-
specific” but the rest of the cases may be due to other causes and therefore must diagnose and 
treat "specifically" and quickly (Van Tulder MW & COST B13 working group 2006). 
Chronic pain lasts more than 3 months and constitutes about 10% of cases, but which 
generates higher costs. 
This classification may seem simplistic since in many cases the pain yields around 6 weeks, 
why is has introduced the term subacute to see episodes that reach between 6 and 12 weeks 
and are warning signs (“Yellow flags”) that requires new evaluations and treatments. 
(Burton A.K. & COST B13 working group 2006). The key to preventing acute pain 
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occurrence and chronicity is implementation of preventive measures (Burton AK & COST 
B13 working group 2006). 
Can be integrated into low back pain clinical course; diagnostic, therapeutic and preventive 
actions so optimize long term results (table 1).  
Course of LBP Red Flags Yellow Flags 
  
Acute (< 6 weeks)) 
Information 
Rule out red flags 
No routine Radiology 
Stay active + Analgesics  
Muscle relaxants 
(optional) 
Aware Yellow Flags 
 
Subacute (6-12 weeks) 
 
Expectations of patient 
Regular Re-assessment 
Active treatments 
Cognitive behavioral 
therapy 
Multidisciplinary 
Occupational 
programme for workers? 
 
Chronic (> 12 weeks) 
Low disability: simple 
therapies 
Severe disability: 
biopsychosocial 
Systemic disease: 
Pain < 20 or > 50 age. 
Thoracic spine pain 
Deficit Neurologic 
Deformity, not flexion of 5th 
Bad general State, fever 
Trauma or Neoplasms 
Use of corticosteroids 
Addictions 
Immunodeficiency, AIDS 
 
Surgery 
 
Urgent : Paresis, loss of control of 
sphincters, "saddle" anesthesia 
Consultation : 6 Weeks of treatment, 
limitation of ambulation. Radicular 
pain > 6 months + image of spinal 
stenosis 
  
Emotional problems  
Depression, low 
morale, and social 
withdrawal 
Use / Abuse of psicho-
mimetics 
 
Inappropriate attitudes 
and beliefs about pain  
 
"pain is harmful or 
disabling" 
"passive, rather than 
active, treatment 
will be beneficial" 
Inappropriate pain 
behavior  
 
Fear and reduced 
activity levels 
Social, Financial 
problems  
Labour disputes 
 
Table 1. Current status and management of LBP and warning signs changed (Van Tulder & 
Araksinen 2006) 
3.2 Basis of spinal pain 
Not only low-back pain is a clinical entity, but also a psycho-social and economic problem. 
It seems that relationship exists between adoption of bipedal position and biomechanical 
changes of musculoskeletal, spine aging, loss of exercise capacity and stamina, working 
conditions, personal expectations, psychological state, intersocial relationship, with low 
back pain. These aspects are detailed in other chapters, but introduce variables that increase 
the complexity of diagnosis management and treatment results. 
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This multidimensional mechanism has generated different handlings for different specialties 
for decades producing poor results, however since publication of Bio-psycho-social model in 
1977, with adoption of management models based on evidence and cost-effectiveness, has 
been creating multidisciplinary teams integrating information and improving outcomes 
(Kovacs FM, 2006). 
However he tends in some areas to excessive psycho-social reductionism and based 
exclusively on this model of treatment, leaving the Neurophysiologic model which based 
part of the treatment on interventional techniques (Manchikanti L, 2009). 
Clinical application of nerve blockade or surgical techniques on the focus and pain pathway, 
has emerged as response to need for action on physical structures that generate, but arising 
in many cases studies with poor methodological quality and so not supported Meta-
analysis, generating controversy. 
Techniques "not recommended" in various guides ( COST B13, RCGP UK) are being revised 
based on improvements in the quality of study design, include studies of cost-effectiveness, 
and therefore possibly be integrated into new "reviews" (Latorre E., 2008). 
4. Critical appraisal & methodology of scientific evidence 
The Begining of medicine until today, the concern has been to provide the best possible 
assistance, applying means proper diagnosis and optimal treatment. The Hippocratic 
principle is relevant for people with pain.  
Since the development of science in the industrial era until today, we have attended to the 
improvement of the scientific method, and in turn the dissemination of information, which 
in recent years is massive. However in what affects the biomedical sciences, have originated 
important defects because at present we do not have instruments of ratification of the 
veracity of the information and analysis to make checks at the same speed that discovered 
new treatments or diagnostic applications. 
At the moment we have a method, perfected from the 20th century, involving the 
application of the ”Critical Analysis” of the scientific literature, and ”Systematic Reviews” & 
”Meta-Analysis” for development of clinical practice guidelines based on what really is 
helpful, so try to minimize the variability of medical practice and clinical research. 
However this process is expensive, slow and is occasionally provide obsolete results at the 
time of its publication and dissemination. 
The scientific method have been based on the three classical premises (elaboration of 
hypothesis, experimentation and analysis, and conclusion) to another more complex process 
that we intend to explain to the reader and allows you to start or improve their skills in the 
development of strategies for applied research in the clinic practice, following our 
experiences.  
The script indicated below is intended to achieve a systematization to avoid biases  that are 
generated throughout the process and thus increase the reliability of the results: 
- Approach to the issue to investigate 
- Scope of the topic of research 
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- Collection and analysis of existing information 
- Assessment of the methodological quality of the detected evidence 
- Development, review and approval 
- Conflicts of interest statements 
- External and editorial review 
- Dissemination of the results of the research 
We understand that they may be useful basic facets as the description of the method of 
critical analysis of the publications and resources for clinical research provided by various 
institutions and entities, which have electronic edition of easy access, which includes 
chapters of methodology and practical aid as well as the possibility of on-line training. 
Given the limited scope of the chapter we have narrated in the first place a brief description, 
but we urge strongly are consulted for its value. 
4.1 Critical reading 
Critical reading is a technique that allows increase effectiveness our reading, acquiring 
necessary skills to exclude low quality scientific articles and accept others to help our 
decision-making process for care of patients. 
Scientific articles should be evaluated in three aspects: 
 Validity:  
Confident in validity of results? The criteria of methodological validity articles are different 
for different questions: treatment, diagnosis, prognosis, economic evaluation... Depending 
on validity, an article may be classified in evidence levels scale, and grades of 
recommendation. 
 Effects and Precision: 
How do results measure the effect? Are results accurate? 
 Applicability: 
Are these results in my middle applicable? 
There are quality scales will help us evaluate job quality in a simple way. In the example 
before us, we used the ”Jadad quality scale” to rate on a range of zero to 5 points: 
- Does the study random assignment? IF = 1 POINT; NOT = 0; If random assignment was 
explained and suitable gives 1 point and if wasn't it him remains. 
- Meet the study criteria of double-blind? IF = 1 POINT; NOT = 0; If the double blind is 
unspoken and applied adequately is assigned 1 point and if does not take away. 
- Are described withdrawals and dropouts from the study? IF = 1 POINT; NO = 0  
There is also a rating system “Validation Level Pain of Oxford” (The Oxford Pain Validity 
Scale: IPOs) with a maximum of 16 points. 
This scale has been developed to test internal validity pain trials and their results. The scale 
assigns points to an essay based on the number of patients in each treatment group, whether 
or not study satisfies criteria of blind or not and if this is correct, used results, summary test 
statistics and if these results or evidence were properly employed.   
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The Evidence-based medicine (on Systematic reviews & Meta-analysis), have become 
increasingly in health care. They are often used as a starting point for developing clinical 
practice guidelines (Green S et al., 2007). 
A systematic review is a review of to clearly formulated question that uses systematic and 
explicit methods to identify, select and critically appraise relevant research, and to collect 
and analyze data from the studies that are included in the review. 
Meta-analysis refers to the use of statistical techniques in a systematic review to integrate 
the results of included studies.  
REVIEW 
Attempt of synthesis of findings and conclusions of two or 
more publications related to a theme. 
SYSTEMATIC 
Review with exhaustive identification of all literature, quality 
assessment and synthesis of results of a given subject. 
META-ANALYSIS 
Systematic review incorporating a specific statistical strategy 
bring together results of several studies on a single estimate. 
Table 2. Sackett D et al. Clinical Epidemiology: A basic science for clinical medicine 2nd ed. 
Little, Brown & Company, 1991. 
4.2 Resources 
Unfortunately medical reviews are subjective, scientifically unsound, and often inefficient 
(Group VPC-IRYS, 2005). Strategies for identifying and selecting information are rarely 
defined. Collected information is reviewed haphazardly with little attention to systematic 
assessment of quality. Under such circumstances, cogent summarization is an arduous not 
insurmountable task. 
Experts from different areas, such as appropriate specialists, statisticians, and research 
methodologists, can be used both to help develop standardized appraisal forms and to rank 
data.Resources used for these purposes have also access program and provide training and 
support for clinical research, are the following: 
4.2.1 Search, bibliographic databases systems. 
They are varied and known of published articles (Medline, Lilacs, Embase) and unpublished 
as recognized research centers internationally accessible through institutional web pages. 
4.2.2 QUOROM Statement 
To address suboptimal reporting of meta-analysis, an international group developed a 
guidance called “QUOROM Statement” (QUality Of Reporting Of Meta-analysis), which 
focused reporting meta-analysis of randomized controlled trials (RCT) (Moher D, 1999). 
4.2.3 COCHRANE Collaboration  
Stimulus for systematic reviews has come from hand of Cochrane Collaboration. Archie 
Cochrane was a wake-up call to underline how collected evidence through RCTs could 
affect medical practice. 
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Acknowledged that professionals interested in making their decisions based on the best 
evidence found had no real access to this information and much less elaborate results. 
In 2008 changed “Cochrane Handbook Reviewer” version 5, which serves to help authors 
reviews explicit and systematic development. Collaboration also has interesting possibilities 
for training and development on its website and is accessible at http://www.cochrane-
handbook.org . 
Available in Spanish, access is universal and free thanks to the subscription by Ministry of 
Health and Social Policy. 
The edition of the Web site (Cochrane.es) is borne by the Iberoamerican Cochrane Centre 
located in “Hospital de la Santa Cruz and San Pablo” of the Autonomous University of 
Barcelona, also contribute to maintenance activities “Instituto de Salud Carlos III”, as 
Ministry of Health. 
Handbook Website offers a multitude aid to health professional, investigator or public. 
Includes resources for users of Cochrane Library plus, design reviews, introduction to 
authors research methodology in English, manual search and training. Access to finished 
clinical practice guides, program of skills of reading criticism, the Center for evidence-based 
medicine and evidence-based health care. 
4.2.4 Bandolier 
Bandolier is a health resource for physicians, evidence based, available over Internet 
(http://www.ebandolier.com ) print as a monthly magazine, primarily in United Kingdom. 
The wealth of information based on evidence that contains Bandolier appears mainly in 
form of short articles and systematic reviews on various conditions and medical 
interventions. Information submitted in concisely and already performed, mainly in 
”Number Needed to Treat” (NNT). 
From Bandolier home page, is an Oxford Pain link Internet Site, with various systematic 
reviews summaries previously published on acute and chronic pain. 
Another link leads to Pain Research Unit, Oxford, which contains detailed information on 
current and past research. 
4.2.5 PRISMA (PRoposal to Improve the publication of Systematic reviews and Meta-
Analysis) 
QUORUM statement was published 1999 in order to establish objective standards that 
improve quality reporting randomized trials meta-analysis. Contains checklist with 18 
sections that allow researchers and editors certify work quality that will be published, and a 
flow diagram describe the process.  
PRISMA (2009) statement arises to update and expand aspects of QUORUM which had 
deficiencies and enable acceptance of editors those standards of quality. Consists of 27 items 
and a ellaboration process of guidelines as well as 7 tables that explain key aspects of 
methodology and conduction of systematic reviews. New features in PRISMA are: adoption 
of COCHRANE collaboration terminology, application extension scope, not only systematic 
reviews of randomized trials, but also for other study types. 4 new aspects are: 
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- After publication Protocol to reduce the impact of biases. 
- Distinction between driving and research study publication. 
- Evaluation risk of bias through studies or outcomes. 
- The importance of publication bias. 
Detailed tables and diagrams information is available at http://www.Prisma-statement.org. 
Main differences between QUOROM (Quality Of Reporting Of Meta-analysis) and PRISMA 
arethe relating to: 
 Flow diagram more detailed and informative. PRISMA based on randomized clinical 
trials, and have useful for meta-analysis as QUOROM, trials continues with total 
number of records or unique citations and ends with individual studies included in 
qualitative synthesis (systematic review) and quantitative (meta- analysis). 
 Establishes differences at each stage process between records or references, articles to 
full and individual studies. 
 Includes format peak (description of participants, interventions, comparisons and 
outcomes). 
 Explanation of previous Protocol to review and access medium. 
 Strategies for electronic search and evaluation risk bias. 
 Extent text increases expense of improving clarity and transparency of information. 
4.2.6 EQUATOR Network (Enhancing the QUality and transparency Of Health 
Research) (Altman & Simera, 2008) 
Is a network of resource development aimed at improving the quality of publications in 
health sciences, this has provided assistance through its website ( http://www.equator-
network.org/) that allow a single researcher as well as groups, teach design guidelines for 
developing quality and transparency. (Liberati A, 2009) 
4.2.7 CONSORT declaration (Consolidated Standards of Reporting Trials)  
This led to clinical trials improve quality methodology and resources publication as 
CONSORT statement, 25 items checklist set of recommendations and a flow diagram 
development progress. 
Objetives are to assist preparation, transparency, critical review and interpretation of 
Randomized Controlled Trials (RCT).  
The first version of 2001 has been revised and perfected in 2010 and includes on its website 
(http://www.consort-statement.org/) additional resources such as CONSORT "Explanation 
and Elaboration" document and CONSORT Library of examples of good reporting. 
Pureed both access to Downloads, Evidence Database, Glossary, Related Instruments, and 
link to Useful sites as for example EQUATOR 
Members of CONSORT Group continually monitoring literature. Information gleaned from 
these efforts provides an evidence base on which to update CONSORT statement. We add, 
drop, or modify items based on that evidence and recommendations of “CONSORT Group”, 
an international and eclectic group of clinical reserarchers, epidemiologists, statisticians, and 
biomedical editors. More than 400 journals, published around the world and in many 
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languages, have explicitly supported CONSORT statement. However, there is a significant 
limitation based on this instrument orientation, which is limited to two-group, parallel 
randomized, controlled trials (RCT) .The items should elicit clear pronouncements of how 
and what authors did, but do not contain any judgments on how and what authors should 
have donate. Moreover, CONSORT 2010 Statement does not include recommendations for 
designing and conducting randomized trials (Schulz K 2010). 
4.2.8 AGREE instrument (Appraisal of Guidelines Research and Evaluation in Europe)  
Defines European criteria standards for preparation clinical practice guidelines (GPC). Is 
available for researchers in http://www.agreecollaboration.org. Assesses both, Information 
of quality of document provided and some aspects of recommendations. Provides validity 
guide. Means quality clinical practice guideline confidence that potential biases of the 
development of the guide have been identified in an appropriate manner and that 
recommendations are valid both internally and externally, and can lead to practice. 
Designed to evaluate guidelines developed by local, regional, national or international 
groups as governmental organizations. Applicable to published guides in paper and 
electronic format. AGREE consists of 23 key items organized in six areas. Each area tries to 
cover a dimension differentiated quality of the Guide: 
Domains of AGREE Appraisal Instrument II 
 Scope & Purpose (1,2,3) objective, health question and population specifically 
described. 
 Stakeholder involvement (4,5,6) Relevant professional groups, Views and 
preferences of the target population, Target users defined. 
 Rigour of Development (7-14) Systematic search, Criteria, strenghs and 
limitations, metods of formulating recommendations, health benefits, side effects 
and risks, explicit link beetwin recommendation and evidences, Externally 
reviewed by experts, procedure updating provided. 
 Clarity of Presentation (15-17) Recommendations specific / ambiguous, different 
management options, Key recommendations identifiable. 
 Applicability (18-21) describe barriers/facilitators, Advices/Tools to put in 
practice, Potential resource implications, Monitoring / Auditing. 
 Editorial Independence (22, 23) Not influence of Publisher, Conflicts of interest 
group members.  
Table 3. Appraisal of Guidelines Research and Evaluation in Europe Instrument AGREE II  
Aims and scope (items 1-3) refers to the overall purpose of the Guide to clinical specific 
questions and target patient population. 
Participation of those involved (items 4-7) refers to the degree in which the Guide 
represents the views of users to which it is intended. 
Rigor in drawing up (items 8-14) refers to the process used to gather and synthesize 
evidence, to formulate recommendations and methods for updating them. 
Clarity and presentation (items 15-18) deals with the language and format of the Guide. 
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Applicability (items 19-21) refers to the possible implications of the implementation of the 
guidance on organizational aspects, behavior and costs. 
Editorial independence (items 22-23) has to do with the independence of the 
recommendations and the recognition of the potential conflicts of interest by the group. 
At the present time there is only another validated scale which assesses the quality of the 
GPC (Shaneyfelt TM, 1999), but a comparative study between these two instruments (Rich 
R, 2004) shows that the instrument AGREE, as well as being that in this moment has greater 
acceptance and provides a more manageable format, manages to make a grouping of criteria 
more clearly and fully. In recent years he has tried to improve the validity of this instrument 
and value items that better assess the quality of a guide; as a result is the development of the 
II AGREE to replace the original version (AGREE, 2009).  
4.3 Recommendations for the process of research development 
The fundamental steps to be taken in the development process include the sections 
described as selection of the topic to research, defining the scope of the review of existing 
scientific evidence and the process of development, revision, and approval of the 
recommendations. Furthermore today should be added others relating to the integrity of the 
members of the research team, transparency and editorial independence, utility, and the 
costs. 
4.3.1 Previous guidelines and state of the question 
One of the first evidence-based clinical practice guidelines for management of low back pain 
was published by “The Quebec Task force on spinal Disorders” in 1987.Using an explicit 
scientific basis found insufficient evidence to support the use of most common diagnostic 
procedures and treatment modalities. 
The U.S. Agency for Health Care and Policy Research (AHCPR) convened a 
multidisciplinary panel of experts issued recommendations on management of Acute Low 
Back Pain (LBP) in 1994, however none of the 40 recommendations made for clinical care 
were viewed as support by strong research evidence, and only 6 by at least moderate 
quality.  
More than eleven international guidelines have been published since 1994, but their 
diagnostic and therapeutic recommendations are similar. Only there are few discrepancies 
to recommendations for exercise, spinal manipulation, muscle relaxants and patient 
information that reflect contextual differences between countries without signification. 
The most interesting from a methodologic point of view are the U.S. Guideline issued by the 
Veterans Affairs/Department of Defense (VA/DoD) in 1999, the Guideline of Royal College 
of General Practicioners (RCGP) initially released in 1996 and updated in 1999 , and the 
European COST B 13 Guidelines. 
The European Multinational COST B 13 program was developed by The European 
Commission Directorate General Research Political Co-Ordination and Strategy branch 
under the title “Low Back Pain: Guidelines for its management”. Since 1999 to 2005 were 
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reviewed 74 clinical practice guidelines and 871 Systematic Reviews, Randomized control 
trials (RCT´) and Prevention studies. Involving a total of 49 experts including 
Epidemiologists, Public Health, Chiropractors, Psychologists, Physiotherapists, 
Ergonomists, Physiologists, and Medical Specialists (Primary Care, Anesthesiology, Pain 
Terapy, Rheumatology, Traumatology, Neurosurgery, Pathology, Rehabilitation, Radiology, 
Sports Medicine, Emergency Medicine and Occupational Medicine.). The main difference 
with previous guides is that COST B13 Guide includes recommendations for management 
Acute, Chronic and prevention of LBP. 
In 2009 the American Pain society (APS) has issued a new clinical practice guideline that 
emphasizes the use of non-invasive treatments over interventional procedures, published of 
the journal Spine. Based on a extensive review of existing research , this review 913 citations 
for systematic reviews, 265 full text articles for inclusion, of those 186 met inclusion criteria. 
Identifies 7591 citations from 44 searches for primary studies , from these, 202 primary 
studies were relevant. For Interventional Therapies and surgery a total of 1331 citations. 
However controversy is served because reaffirm previous recommendations (see COST B13 
Guide) that avoid invasive therapies and showing benefits of non-invasive (stay active, 
intensive rehabilitation and cognitive/behavioural emphasis). In contrast the American 
Society of Interventional Pain Physicians has been published a critical review of 
Interventional Techniques for chronic and acute LBP (2010) that differs from APS Guidelines 
including caudal epidural injections, lumbar facet joint nerve blocks, radiofrequency 
neurotomy, and percutaneous adhesiolysis as appropriate methodology. 
Probably better designed studies obtain a balance between non-invasive and interventional 
therapies. 
4.3.2 Key points of systematic reviews and LBP 
A systematic review is a complex process, but we want to emphasize the fundamental 
aspects of methodology.  
1. Selection of Topics 
Choosing a topic is the first step in development process. We must consider the following 
criteria: effect of condition on morbidity , mortality , prevalence of back pain , areas of 
uncertainty evidence , cost, relevance and availability of developed recommendations. 
2. Scope of Topics 
Address screening , diagnosis and treatment of back pain focus on the effectiveness of 
interventions , cost and cost-effectiveness. 
3. Review of Evidence for Clinical Recommendations 
Evaluating Evidence. 
The key questions and scope for the evidence–review papers are developed from the 
Clinical Guidelines Committee. The evidence review paper is a comprehensive systematic 
review of meta-analysis that address to management of back pain. Specifies the criteria that 
are used to identify evidence related to each the key questions for inclusion in the review. 
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Quality of evidence were evaluated using the AHCPR Guide and “The Levels of Evidence” 
recommended for The Back Group of Cochrane Collaboration (van Tulder 2003). Evidence 
reviews provide information about whether the studies included are reliable and accurate 
and provide reasonable assessments of potential adverse effects, information on systematic 
gaps particularly with respect to areas of clinical importance or relevance. 
Statistical Review. 
The evidence reviews also go through a statistical peer-review process to staticians during 
its early stages of development. 
A three-stage development process was undertaken. First, recommendations were derived 
from systematic reviews. Secondly, existing national guidelines were compared and 
recommendations from these guidelines summarised. Thirdly, the recommendations from 
the systematic (Cochrane) reviews and guidelines were discussed by the group. A section 
was added to the guidelines in which the main points of debate are described. The 
recommendations are put in a clinically relevant order; recommendations regarding 
diagnosis have a letter D, treatment T. A grading system was used for the strength of the 
evidence. This grading system is simple and easy to apply, and shows a large degree of 
consistency between the grading of therapeutic and preventive, prognostic and diagnostic 
studies. The system is based on the original ratings of the AHCPR Guidelines (1994) and 
levels of evidence recommended in the method guidelines of the Cochrane Back Review 
group. Several of the existing systematic reviews have included non-English language 
literature, usually publications in French, German, and Dutch language and sometimes also 
Danish, Norwegian, Finnish and Swedish. All existing national guidelines included studies 
published in their own language. Consequently, the non-English literature is covered for 
countries that already have developed guidelines. 
The group additionally included the Spanish literature, because this evidence was not 
covered by existing reviews and guidelines. 
The Working Group aimed to identify gaps in the literature and included recommendations 
for future research. 
4.3.3 Methodological quality of studies and levels of evidence 
A grading system was used for the strength of the evidence. This grading system is simple 
and easy to apply, and shows a large degree of consistency between the grading of 
therapeutic and preventive, prognostic and diagnostic studies. The system is based on the 
original ratings of the AHCPR Guidelines (1994) and levels of evidence used in systematic 
(Cochrane) reviews on low back pain. 
Level of evidence: 
1. Therapy and prevention: 
Level A: 
Generally consistent findings provided by (a systematic review of) multiple high quality 
randomised controlled trials (RCTs). 
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Level B: 
Generally consistent findings provided by (a systematic review of) multiple low quality 
RCTs or non-randomised controlled trials (CCTs). 
Level C: 
One RCT (either high or low quality) or inconsistent findings from (a systematic review of) 
multiple RCTs or CCTs. 
Level D: 
No RCTs or CCTs. 
Systematic review: systematic methods of selection and inclusion of studies, methodological 
quality assessment, data extraction and analysis. 
2. Prognosis: 
Level A: 
Generally consistent findings provided by (a systematic review of) multiple high quality 
prospective cohort studies. 
Level B: 
Generally consistent findings provided by (a systematic review of) multiple low quality 
prospective cohort studies or other low quality prognostic studies. 
Level C: 
One prognostic study (either high or low quality) or inconsistent findings from (a systematic 
review of) multiple prognostic studies. 
Level D, no evidence: 
No prognostic studies. 
High quality prognostic studies: prospective cohort studies Low quality prognostic studies: 
retrospective cohort studies, follow-up of untreated control patients in a RCT, case-series 
3. Diagnosis: 
Level A: 
Generally consistent findings provided by (a systematic review of) multiple high quality 
diagnostic studies. 
Level B: 
Generally consistent findings provided by (a systematic review of) multiple low quality 
diagnostic studies. 
Level C: 
One diagnostic study (either high or low quality) or inconsistent findings from (a systematic 
review of) multiple diagnostic studies. 
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Level D, no evidence: 
No diagnostic studies. 
High quality diagnostic study: Independent blind comparison of patients from an 
appropriate spectrum of patients, all of whom have undergone both the diagnostic test and 
the reference standard. (An appropriate spectrum is a cohort of patients who would 
normally be tested for the target disorder. An inappropriate spectrum compares patients 
already known to have the target disorder with patients diagnosed with another condition) 
Low quality diagnostic study: Study performed in a set of non-consecutive patients, or 
confined to a narrow spectrum of study individuals (or both) all of who have undergone 
both the diagnostic test and the reference standard, or if the reference standard was 
unobjective, unblinded or not independent, or if positive and negative tests were verified 
using separate reference standards, or if the study was performed in an inappropriate 
spectrum of patients, or if the reference standard was not applied to all study patients. 
The methodological quality of additional studies will only be assessed in areas that have not 
been covered yet by a systematic review or of the non-English literature. 
The methodological quality of trials is usually assessed using relevant criteria related to the 
internal validity of trials. High quality trials are less likely to be associated with biased 
results than low quality trials. Various criteria lists exist, but differences between the lists are 
subtle. 
Quality assessment should ideally be done by at least two reviewers, independently, and 
blinded with regard to the authors, institution and journal. 
However, as experts are usually involved in quality assessment it may often not be feasible 
to blind studies. Criteria should be scored as positive, negative or unclear, and it should be 
clearly defined when criteria are scored positive or negative. Quality assessment should be 
pilot tested on two or more similar trials that are not included in the systematic review. A 
consensus method should be used to resolve disagreements and a third reviewer was 
consulted if disagreements persisted. If the article does not contain information on the 
methodological criteria (score ‘unclear’), the authors should be contacted for additional 
information. This also gives authors the opportunity to respond to negative or positive 
scores. 
The following checklists are recommended: 
4.3.4 Checklist for methodological quality 
Checklist for methodological quality of therapy / prevention studies 
Items: 
1. Adequate method of randomisation, 
2. Concealment of treatment allocation, 
3. Withdrawal / drop-out rate described and acceptable, 
4. Co-interventions avoided or equal, 
5. Blinding of patients, 
6. Blinding of observer, 
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7. Blinding of care provider 
8. Intention-to-treat analysis, 
9. Compliance, 
10. Similarity of baseline characteristics. 
Checklist for methodological quality of prognosis (observational) studies 
Items: 
1. Adequate selection of study population, 
2. Description of in- and exclusion criteria, 
3. Description of potential prognostic factors, 
4. Prospective study design, 
5. Adequate study size (> 100 patient-years), 
6. Adequate follow-up (> 12 months), 
7. Adequate loss to follow-up (< 20%), 
8. Relevant outcome measures, 
9. Appropriate statistical analysis. 
Checklist for methodological quality of diagnostic studies 
Items: 
1. Was at least one valid reference test used? 
2. Was the reference test applied in a standardised manner? 
3. Was each patient submitted to at least one valid reference test? 
4. Were the interpretations of the index test and reference test performed independently 
of each other? 
5. Was the choice of patients who were assessed by the reference test independent of the 
results of the index test? 
6. When different index tests are compared in the study: were the index tests compared in 
a valid design? 
7. Was the study design prospective? 
8. Was a description included regarding missing data? 
9. Were data adequately presented in enough detail to calculate test characteristics 
(sensitivity and specificity)? 
4.3.5 Inclusion of non-English language literature 
Background 
There is still an ongoing debate about inclusion in systematic reviews of studies published 
in other languages than English. Although inclusion of non-English literature is often 
recommended, it may not always be feasible and may depend on the time and resources 
available. Some authors suggested that there is empirical evidence that exclusion of trials 
published in other languages than English might be associated with bias. Positive results 
by authors from non-English speaking countries are more likely to be published in 
English and negative results in the authors' language. They found an example of a meta-
analysis where inclusion of a non-English language trial changed the results and 
conclusion. 
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Authors of German-speaking countries in Europe were more likely to publish RCTs in an 
English-language journal if the results were statistically significant. On the other hand, 
Moher et al. (1996) evaluated the quality of reporting of RCTs published in English, French, 
German, Italian and Spanish between 1989 and 1993 and did not find significant differences. 
Trials published in some non-English languages (Chinese, Japanese, Russian and 
Taiwanese) had an unusually high proportion of positive results. 
Excluding trials published in other languages than English generally has little impact on the 
overall treatment effect. 
Although the evidence seems to be inconclusive, most authors concluded that all trials 
should be included in a systematic review regardless of the language in which they were 
published, to increase precision and reduce bias. The Cochrane Back Review Group 
recommended in its method guidelines for reviews on low back pain that if RCTs published 
in other languages are excluded from a review, the reason for this decision should be given. 
(van Tulder et al 2003) Especially on topics where there are likely to be a significant number 
of non-English language publications (for example, the Asian literature on acupuncture) it 
may be wise to consider involvement of a collaborator with relevant language skills. The 
members of the Working Group acknowledged that a different literature search should be 
performed for non-English literature than for the English literature. Databases do not exist 
for most other languages, the reliability and coverage of the databases that do exist is 
unclear, and sensitive search strategies for these databases may not have been developed. 
Most of the systematic reviews used in the European guidelines included trials published in 
English and some other languages (mostly German, French, Dutch and sometimes Swedish, 
Danish, Norwegian and Finnish). Obviously, the national guidelines that we have used as 
basis for our recommendations have included studies published in their respective 
languages. National committees that developed guidelines in these languages have 
considered Danish, Dutch, Finnish, French, German, Norwegian and Swedish language 
studies. Only Italian and Spanish trials have yet not been considered, because guidelines in 
these countries do not exist. 
Because there was no Italian member participating in the WG, we only considered the 
Spanish literature. 
Objectives 
To summarise the evidence from the Spanish literature and evaluate if it supports the 
evidence review and recommendations of the guidelines. 
Methods 
Literature search 
Relevant trials were identified in existing databases: Literatura Latino Americana e do 
Caribe em Ciencias da Saude (LILACS) and Índice Médico Español (IME). The 
Iberoamerican Cochrane Centre (Centro Iberoamericano de la Colaboración Cochrane ) was 
contacted for additional trials. 
Inclusion criteria are: 1) randomised controlled trials, 2) acute and subacute low back pain 
(less than 12 weeks), and 3) any intervention. 
www.intechopen.com
 Low Back Pain 52
Quality Appraisal 
The abstracts with no English version have been translated from Spanish by a native English 
speaker. Some papers had an English version of their abstracts. In these cases, the translator 
has just done a linguistic review of them and, in those cases in which the Spanish and 
English versions did not match, a translation of the Spanish abstract has been done. Some 
Spanish journals publish only short reports of the studies (similar to abstracts). In these 
cases, the entire report has been considered as the abstract. Other Spanish journals have a 
mandatory structure for the abstracts they publish, which may have changed over time, but 
most do not. Therefore, there is a considerable difference in the amount of information 
provided by different abstracts. 
Two reviewers assessed the quality of the trials using the checklist for methodological 
quality of therapy/prevention studies. 
Data extraction 
Data were extracted regarding characteristics of patients, interventions and outcomes (pain, 
functional status, global improvement, return to work, patient satisfaction, quality of life, 
generic functional status and intervention-specific outcomes) and the final results of the 
study for each outcome measure at each follow-up moment. 
Data analysis 
The results of the Spanish literature (quality, data and results) were considered by the 
members of the WG to see if the results do or do not support the recommendations. If not, 
reasons for these inconsistencies were explored. 
4.4 Dissemination and implementation 
Clinical guidelines are usually defined as ‘systematically developed statements to assist 
practitioner and patient decisions about appropriate health care’ as a vehicle for assisting 
health care providers in grasping new evidence and bring it into daily clinical routines for 
improving practice and for diminishing costs. 
Implementation of guidelines means putting something (e.g. a plan or an innovation) into 
use. The process of spreading clinical guidelines implies diffusion, active dissemination and 
implementation. Diffusion is a passive concept while dissemination is a more active process 
including launching of targeted and tailored information for the intended audience. 
Implementation often involves identifying and assisting in overcoming barriers to the use of 
the knowledge obtained from a tailored message. 
Normally implementation procedures mean a multi-disciplinary enterprise. 
Effectiveness of interventions 
Success in the implementation process requires knowledge about important factors behind 
general positive and negative attitudes towards guidelines related to usefulness, reliability, 
practicality and availability of the guidelines. Also the overall individual, team and 
organisational competence to follow recommended procedures seem to be vital. 
Systematic reviews of the effectiveness of interventions to promote professional behaviour 
or change have shown: 
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Consistently effective are 
 Educational outreach visits (for prescribing in North American settings) 
 Reminders (manual or computerised) 
 Multifaceted interventions 
- A combination that includes two or more of the following: audit and feedback, 
reminders, local consensus process and marketing 
 Interactive educational meetings 
- Participation of health care providers in workshops that include discussions of practice 
Mixed effects 
 Audit and feedback 
- Any summary of clinical performance 
 Local opinion leaders 
- Use of providers nominated by their colleagues as ‘educationally influential’ 
 Local consensus process 
- Inclusion of participating providers in discussion to ensure that they agreed that chosen 
clinical problem was important and the approach to managing the problem was 
appropriate. 
 Patient mediated interventions 
- Any intervention aimed at changing the performance of health care providers where 
specific information was sought from or given to patients.  
- Little or no effect 
 Educational materials 
- Distribution of published or printed recommendations for clinical care, including 
clinical practice guidelines, audio-visual materials and electronic publications. 
 Didactic educational meetings 
- Lectures 
4.4.1 Barriers and facilitators 
A successful implementation of guidelines requires thoroughly performed planning and 
monitoring of the implementation whereof addressing barriers and facilitators appear to be 
of vital importance to enhance the implementation process. Before starting the 
implementation such barriers and facilitators should be systematically recorded among 
target groups for applying the clinical guidelines. 
Potential barriers to change may include: 
Practice environment 
 Limitations of time 
 Practice organisation, e.g. lack of disease registers or mechanisms to monitor repeat 
prescribing. 
Educational environment 
 Inappropriate continuing education and failure to link up with programmes to promote 
quality of care 
 Lack of incentives to participate in effective educational activities  
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Health care environment 
 Lack of financial resources 
 Lack of defined practice populations 
 Health policies which promote ineffective or unproven activities 
 Failure to provide practitioners with access to appropriate information 
Social environment 
 Influence of media on patients in creating demands/beliefs 
 Impact of disadvantage on patients’ access to care 
Practitioner factors 
 Obsolete knowledge 
 Influence of opinion leaders 
 Beliefs and attitudes (for example, related to previous adverse experience of innovation) 
Patient factors 
 Demands for care 
 Perceptions/cultural beliefs about appropriate care 
Implementation strategies should be tailored according to recorded identified barriers and 
facilitators. How to do this is described in detail in Evidence Based Practice in Primary Care. 
Evaluation 
In general it is also recommended to evaluate outcome and result of the implementation 
process. Outcome measures related to low back pain will often be before and after status of 
use of health services, for instance x-ray, sickness absence and back related health status of 
the patient population (e.g. pain, function/quality of life). Types of evaluation may include 
RCTs, cross-over and semi-experimental trials, before-after study and interrupted time 
series analyses. An economic evaluation is also required on both the course and the benefits 
of implementation analysis. 
Oxman et al. reviewed 102 randomised controlled trials in which changes in physician 
behaviour were attempted through means such as continuing medical education workshops 
and seminars, educational materials, academic detailing and audit and feedback. Each 
produced some change but the authors concluded that a multi-faceted strategy was called 
for using a combination of methods and that there can be no “magic bullet” for a successful 
implementation. 
4.5 Search strategy for the systematic reviews 
Literature search, conducted 11.12.2001 
Databases 
1. Cochrane 
2. Medline 
3. Health Star 
4. Embase 
5. Pascal 
6. Psychoinfo 
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7. Biosis 
8. Lilacs 
9. IME (Índice Médico Español) 
Search Strategy: 
1. Cochrane: #·1 Back pain. 
2. Medline and Health Star: 
a. sensitive strategy: 
#1 (back pain) AND systematic[sb] 
#2 (back pain) AND systematic[sb] Field: All Fields, Limits: 
Publication Date from 1990 
b. specific strategy: Adding: 
#3 (back pain) AND systematic[sb] Field: All Fields, Limits: 
Publication Date from 1990, Review 
3. Embase: #1 Back pain. De (MESH) 
#2 Low back pain. De (MESH) 
#3 1 OR 2 
#4 Systematic 
#5 3 and 4 (Limitado por Review y publicaciones desde 1990) 
4. Pascal, Psychoinfo and Biosis: 
#1 Back pain 
#2 Low back pain 
#3 1 OR 2 
#4 Systematic 
#5 3 AND 4 (limit to Publication type”Review” and Publication Date since1990) 
5. Lilacs: #1 dolor de espalda. [DE] 
#2 (lumbago) O lumbalgia. [TI] 
#3 (dolor) Y espalda. [TI] 
#4 #1 O #2 O #3 
#5 (revisión) Y sistemática. 
#6 #4 Y #5 
6. IME: #1 (dolor de espalda) O lumbago O lumbalgia. [DE] 
#2 (dolor de espalda) O lumbago O lumbalgia 203 
#3 revisión sistemática 
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#4 #1 Y #3 
#5 #2 Y #3 
RESULTS 
Total hits 
Cochrane 12 
Medline and Health Star 
“Specific”: 121 5 excluded 20 redundant 
“Sensitive” 273 121 redundant with 
Medline specific 
14 excluded 
10 redundant 
Embase 13 1 redundant 
Pascal, Psychoinfo and Biosis 14 2 redundant 
Lilacs 0 
IME 0 
Typical subgroup search 
(e.g. results for physical treatments and exercise) 
Embase 
No. Records Request 
1 9163 back pain 
2 74295 randomized trial 
3 458 #1 and #2 
4 81 exercise and #3 
5 44 training and #3 
6 14 traction and #3 
7 0 bracing and #3 
8 29 manipulation and #3 
9 14 massage and #3 
10 8 heat and #3 
11 5 cold and #3 
12 4 ultrasound and #3 
13 7 tens and #3 
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14 0 electrotherapy and #3 
15 3 diathermy and #3 
16 4 laser and #3 
17 9 manual therapy and #3 
18 4 TNS and #3 
19 1 interferential therapy and #3 
* 20 163 #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or 
#15 or #16 or #17 or #18 or #19 
Psychinfo 
Search History 
#20 #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or 
#13 or #14 or #15 or #16 or #17 or #18 or #19 (6 records) 
#19 interferential therapy and #3 and (PY=1995-2002) (0 records) 
#18 TNS and #3 and (PY=1995-2002) (0 records) 
#17 laser and #3 and (PY=1995-2002) (0 records) 
#16 diathermy and #3 and (PY=1995-2002) (0 records) 
#15 electrotherapy and #3 and (PY=1995-2002) (0 records) 
#14 manual therapy and #3 and (PY=1995-2002) (0 records) 
#13 tens and #3 and (PY=1995-2002) (0 records) 
#12 ultrasound and #3 and (PY=1995-2002) (0 records) 
#11 cold and #3 and (PY=1995-2002) (0 records) 
#10 heat and #3 and (PY=1995-2002) (0 records) 
#9 massage and #3 and (PY=1995-2002) (0 records) 
#8 manipulation and #3 and (PY=1995-2002) (0 records) 
#7 bracing and #3 and (PY=1995-2002) (0 records) 
#6 traction and #3 and (PY=1995-2002) (0 records) 
#5 training and #3 and (PY=1995-2002) (0 records) 
#4 exercise and #3 and (PY=1995-2002) (2 records) 
#3 #1 and #2 (6 records) 
#2 randomized trial and (PY=1995-2002) (352 records) 
#1 back pain and (PY=1995-2002) (645 records) 
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5. Elaboration of a CPG based on scientific evidence. The Spanish version of 
COST B13 European program 
It is a long and complex process that must be completed by a method of work explained in 
part previous sections and follows a basic sequence ( figure 3). The systematic reviews were 
identified using the results of validated search strategies in the Cochrane Library, Medline, 
Embase and, if relevant, other electronic databases, performed for Clinical Evidence, a 
monthly, updated directory of evidence on the effects of common clinical interventions, 
published by the BMJ Publishing Group (www.evidence.org). The literature search covered 
the period from 1966 to October 2005. A search for clinical guidelines was first performed in 
Medline. Since guidelines are only infrequently published in medical journals we extended 
the 5 search on the Internet (using search terms ‘back pain’ and ‘guidelines’, and searching 
national health professional association and consumers websites) and identified guidelines 
by personal communication with experts in the field. 
A three-stage development process was undertaken. First, recommendations were derived 
from systematic reviews. Secondly, existing national guidelines were compared and 
recommendations from these guidelines summarised. Thirdly, the recommendations from 
the systematic (Cochrane) reviews and guidelines were discussed by the group. A section 
was added to the guidelines in which the main points of debate are described. The 
recommendations are put in a clinically relevant order; recommendations regarding 
diagnosis have a letter D, treatment T. 
A grading system was used for the strength of the evidence. This grading system is simple 
and easy to apply, and shows a large degree of consistency between the grading of 
therapeutic and preventive, prognostic and diagnostic studies. The system is based on the 
original ratings of the AHCPR Guidelines (1994) and levels of evidence recommended in the 
method guidelines of the Cochrane Back Review group. The strength of the 
recommendations was not graded. 
Several of the existing systematic reviews have included non-English language literature, 
usually publications in French, German, and Dutch language and sometimes also Danish, 
Norwegian, Finnish and Swedish. All existing national guidelines included studies 
published in their own language. Consequently, the non- English literature is covered for 
countries that already have developed guidelines. 
The group additionally included the Spanish literature, because this evidence was not 
covered by existing reviews and guidelines.  
The Working Group aimed to identify gaps in the literature and included recommendations 
for future research. 
Basic Sequence: 
5.1 Constitution of the multidisciplinary working group  
Constitution of the multidisciplinary working group through a Management Committee 
composed of experts in field of low back pain, appointed by the Governments of 14 
countries participating in European Union, framed in the Directorate General Research, 
Political Co-ordination and Strategy (COST) and B13 program "Low back Pain: Guidelines 
for its management". 
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To streamline the work plan were drafting chapters on acute low back pain, chronic and 
prevention, stratified components in 3 sub-working groups. Finally, in our case was 
working Spanish Group for improvement and adaptation directed by the Spanish 
representatives of European Management Committee. 
5.2 Search and selection of scientific evidence  
Search and selection of scientific evidence by means computerized databases and 
documentary looking time period more comprehensive as possible, with strategies to 
include those available in languages other than English, particularly in Spanish, but also 
supplement with contributions of studies which were undergoing investigation or 
publication, but excluding not accepted. 
Explored databases were Cochrane, Medline, Embase, health Star, Pascal, PsycINFO, SPORT 
ciscos, Biosis, Lilacs and EMI. 
5.3 Methodological evidence quality assessment  
Methodological evidence quality assessment detected in each systematic review and original 
studies found according to Oxman and Guyatt methodological criteria (annex 2 GPC COST) 
5.4 Levels of evidence for recommendations  
Levels of evidence for recommendations arising from number of studies that underlie them, 
quality methodology and consistency results, according to criteria based on guidance of 
advice (Bigos1994) and "levels of evidence" recommended by the Cochrane Collaboration 
back group (van Tulder 2003). (Table 4) 
Level A : Results of a systematic¨ review of multiple studies* (high quality).
Level B : Results of a systematic¨ review of studies* (low quality). 
Level C : Results of a single study * (high or low quality),  
or inconsistent systematic¨ review of multiple studies.  
Level D : Non-obviousness (lack of studies). 
Table 4. Evidence Levels 
¨Criterion of "Systematic review": use of systematic methods to select and include studies, assessment 
of methodological quality and extraction and analysis of data. Are defined as "results consistent to the 
coincidence in the sense of the results, at least 75% of the studies".* Studies: diagnostic, prognosis 
(prospective), treatment (controlled clinical trial), prevention (controlled clinical trial) 
5.5 Review and approval content of Guide  
Review and approval content of Guide once analysed available scientific evidence each 
group developed recommendations and discussion according to a fixed timetable, by 
electronic means and meetings seeing them joint the overall content of the Guide, 
articulating a mechanism of critical inter groups until approval by unanimity. 
5.6 Spanish adaptation by the Working Group  
Spanish adaptation by the Working Group formed with the aim of: 
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5.6.1 Help detect and collect evidence in Spanish  
Help detect and collect evidence in Spanish might have been forgotten in e-strategies prior. 
5.6.2 Critical analysis 
Critical analysis:Successive drafts produced by work groups. 
5.6.3 Adaptation 
To Spanish health system, dissemination and use of GPC elaborated by working groups. The 
Spanish adaptation is stuck studying organizational aspects necessary for recommendations 
implementation, definition targets, measurement organization and registration indicators 
systems, implementation and identification of local barriers to be overcome. 
5.6.4 Application of the criteria of the instrument AGREE 
Application of the criteria of the instrument AGREE, and detection of gaps in the previous 
format (International) as: not-identification of target user, lack of tools to facilitate practical 
application, or establishment methods to make e final recommendations, and non-inclusion 
of declarations interest conflicts. 
5.6.5 Updating of the Guide COST B13 
Through following mechanisms: regular meetings of representatives of participating 
entities, provision of sources of funding for an automated mechanism for detection, analysis 
and aggregation of results of further studies. Use as a basis for updates Cochrane 
Collaboration systematic reviews relating to clinical trials on therapeutic technologies, and 
formation of a network of evaluation teams in studies published in mentioned area. 
5.6.6 Declaration of conflicts of interest 
Economic, effective type or species, direct or indirect, generic or specific, personal or 
collective produced or expected, that goes beyond use of technologies which mentioned in a 
clinical setting or research purposes. Performed in nominal and explicit way by components 
of the Spanish working group and contained in a table extensive version. 
5.7 Guide publication by previously established, varied media  
Written in extended version including a management role and through free electronic access 
algorithm through www.REIDE.org . In GPC said based on scientific evidence, specify all 
relevant studies for each specific recommendation, analyzes town methodology and are 
non-technical summary evidence on efficiency, effectiveness, safety and cost/effectiveness 
and indications of each treatment.  
5.7.1 Algorithm  
Integrates all information is published on paper and you can print from electronic access, 
consists of a flow diagram that includes evidence of each recommended technology and 
designed to take up a minimum space, is Pocket-Guide. 
www.intechopen.com
 The Treatment of Low Back Pain and Scientific Evidence 61 
 
www.intechopen.com
 Low Back Pain 62
 
www.intechopen.com
 The Treatment of Low Back Pain and Scientific Evidence 63 
Clarification of Algorithm 
A For referral to surgery :  
a. Emergency Surgery if progresive or bilateral paresis, loss of bladder control or sadle 
anesthesia. 
b. Severe Radicular pain > 6 weeks despite all non surgery treayments (disc herniation ). Or 
only withwalking, needs flexion or sitting, is longer > 6 months and there are images of 
spinal stenosis. 
B For systemic pathology: values X-ray, simple analysis, MRI in early pain in <20 o > 50 years 
old, dorsal, at night,, neurologic défficit,diffuse, flexion 5º failed, deformation,malaise, loss 
weigth, fever, neoplasms, corticosteroids, trauma, intranenous addictions, inmunosuppression 
or AIDS. 
C Information patient: Avoid bed rest, nonspecific back pain not due to serious illnes, pain 
emanating from structures of the spine, spontaneous resolved  to 2-6 weeks. To speed recoveryand 
reduce the risk of recurrence mantainphysical activity including work if possible. 
D First line Drugs: Paracetamol 650-1000 mgs each 6-8 hours, AINEs < 3 months, muscle 
relaxants < 1 week. 
E Exercise: Not before 2-6 weeks of episode, as preventive and treatment. 
F Neuroreflexotherapy (NRT) : if LBP >2 weeks, moderate to intense (>3 points of 1-10 scale) 
and there are one acredited unit. 
G Signals of Poor functional prognosis 
H Brief Educative Programs: Pocket back Manual, chat with patient for positive reinforcement, 
internet direction with consistent information (www.espalda.org). 
I Cognitive-behavioral treatment: Only if LBP > 6 weeks with signals of poor functional 
prognosis ,potentially active work situation, LBP intense and > 3 months with failure of 
treatments or with exercise instead of surgery in degenerative spondylosis. 
J Back School: Not centered in traditional education but in activity maintenance. 
K Antidepressants: Analgesic dosing. 
L Capsaicin Patches: If intense pain ( >5 points of 1-10 scale) 
M Opiates: Patterned and slow-release with strict medical control. 
N Peripheral Neuro-Stimulation (PNS) 
O Arthrodesis Preferable not instrumented only if disabling pain > 2 years despite all treatments 
maximum 2 segments of spine. 
P Multidisciplinary programs: Intensive and combined D, E, I, K and M , by Psychologist, 
Physiotherapist and Medical staff in specialized units.  
(Based on Figure 1 (Management Algorithm) pg 13-14. And CPG Spanish version pocket guide, 
disposable in www.REIDE.org  
Latorre Marques E., Kovacs F., Gil del Real Mª T., Alonso P., Urrutia G.: Spanish version of COST B13 
Guide: A clinical pactical guideline for non-specific back pain based on scientific evidence. Dolor 2008; 
23: 7-17) 
Fig. 2. Management Algorithm of LBP based on Scientific Evidence. 
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Fig. 3. Development schedule of a CPG based on scientific evidence 
Attached and rear face contains explanatory notes of management; as can be seen is 
integrated into a single temporal sequence low back pain acute, sub-acute and chronic.  
5.7.2 Recommendations summary GPC of low back pain 
Reflected in a 22 page booklet and contains information relating recommended diagnostic 
process, recommended treatments based on scientific evidence, technologies not 
recommended for treatment, prevention of occurrence, or recurrence, and handling 
algorithm. It can also be downloaded on the internet. Includes authors and reviewers, as 
well as relevant national entities adopting recommendations. 
One of novelties is incorporation of treatments cognitive-behavioral early mode and early 
detection of signs of poor functional prognosis by simple and specific tests (Table 5).  
Signs of poor functional prognosis Recommended treatments 
Mistaken beliefs 
Misconduct 
Occupational factors 
Emotional problems 
Interview training 
Written validated information 
Electronic information 
Brief educational program 
Table 5. Signs of poor functional prognosis and recommended treatment 
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6. Discussion 
Until the year 2005 revisions and CPG´s served to help primary care to manage only acute 
low back pain. Few documents provided outcome assessment, until emergence of CPG 
COST B13 program of European Union.  
Inclusion of basic principles management summary and outcome assessment in low back 
pain, that daily practice medicine, scientific evidence based, makes this CPG a reliable 
instrument.  
Our working group decided include "Criteria to define the evidence needed to develop 
recommendations": 
 For studies considered for each analysis group (builds clinicians, in addition to 
controlled clinical trials in chronic low back pain and studies on prevention in the 
corresponding group). 
 Referred to non-specific. 
 Refer to specific field of each group (acute, chronic low back pain and prevention) and 
mechanisms of warning mutual between groups given overlapping populations 
included in systematic reviews or studies. 
 Relevant analysis of variable for each field. In case of treatments for acute and chronic 
low back pain: pain intensity, degree of disability, level of quality of life or absenteeism 
/ return to work. 
Numerous adaptations and improvements (Pillastrini P 2011) have been developed. 
Comparing the quality of the CPG´s from 2004 until today for LBP has improved, however 
developers need to still increase quality transparency process, especially with regard 
editorial applicability and independence (Bouwmeester W, 2009). 
The process of the CPG´s is still costly in economic resources and time, in best cases for up 
to 4 years is therefore possible that arise this period new evidence should incorporate, to 
which review mechanisms should be established involving staff sufficiently prepared both 
clinical management and analysis of the scientific evidence. For this reason must obtain 
support of scientific entities and non-profit publishers to remain independent and 
professionals without conflict of interest. 
In our case, was obtained scientific and professional broadest possible support, described 
favorably by evaluation agencies in health technology, approved by CPG of national health 
system catalog (GuiaSalud), applied in hospitals and health centers. Its use was 
recommended by entities as Council official schools of Spain doctors, but unlike other 
CPG´s included support for consumer organizations in health services. Our version 
identifies concrete entities of explicit, improving transparency. 
However from reading our guide has emerged a contradiction in the meaning of the 
scientific evidence available at that time because we do not recommended the use of 
Botulinum Toxin for chronic low back pain treatment, although at that time there was a 
controlled trial which demonstrated their effectiveness, but after analysis observed low 
methodological quality and low scale of clinical effects reflected without compensating for 
the risks of its use. Also our version not recommended vertebral manipulation, while 
European version was Yes. This is due to the Spanish working group could discuss 
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publications that appeared after first had been released, which showed methodological 
errors that inclined in negative sense and therefore not apply in daily clinical practice, and 
still less be taken in National Health Spanish System (Kovacs FM, 2005). 
Other technologies that have in Spain anecdotal usage data, such as ozone therapy or drug 
enforcement anti-TNF (Tumor Necrosis Factor), were discarded for lack of evidence on 
efficacy, safety or efficiency, after incorporating them by the Spanish working group, to a 
new analysis of quality whose result was negative. 
As evaluated and treatments "not recommended" used in the "treatment of pain unit" also 
disputes that remain have been (American Pain Society, Chou & Hoyt Huffman, 2009) for 
the application of nerve blocks in the treatment of low back pain.  
Sacroiliac Joint Blockade did not provide evidence that special use, even the infiltration with 
corticosteroids is no better than placebo (level C), epidural injections were not 
recommended in non-specific LBP (Level D), however this option can arise in the case of 
root compression symptomatic herniated disc contained and not extruded, obtaining better 
results combined with corticosteroid and local anesthesics and is cost-effective (Karpinen J) 
(2001). Facet injections with corticosteroids were not superior to placebo (level B), and 
combinations of steroids and local anesthetics were similar to anesthetic alone (level C) 
effectiveness, therefore not recommended them. Similarly, infiltrations and electrotherapy 
intra-disc, and facet-joint radiofrequency showed no conclusive data in 2005, probably by 
the poor quality of the studies, but long series has now been re-designed, with assessment of 
cost effectiveness and improvement of methodological quality seem to support its use in 
selected circumstances (Manchikanti L., 2010). 
Other low back pain versions CPG´s lack elicitation in relation to the criteria of 
organizational adaptation to various health services and ensure coordination and efficiency, 
so the Spanish version includes a process for identification of local variations in story to the 
applicability and adaptation mechanisms. 
Given that the Pan-European version finished his project in 2005, we decided to update 
mechanisms, based on the detection and analysis of the evidence that arise in the future, 
marking a timetable for action that also incorporated social and scientific entities to improve 
adherence and outcomes (Spanish working group program COST B13 2005). 
7. Conclusion 
Low back pain is a common and potentially disabling condition in adults, and included 
numerous treatment options. The best available evidence currently suggest that in absence 
of serious spinal pathology, specific causes of non-spinal origin or progressive neurologic 
deficit, management should focus on patient education, self-care, common analgesics and 
exercise.  
Short term relief in radiating pain may be obtained with epidural blockade with local 
anesthetics and steroids, or facet blocks in selected cases. Peripheral Neuromodulation 
(PNS) and Neuro-Reflex-Therapy (NRT) can offer good results in LBP. 
For patients with psychological comorbidities, cognitive-behavioral therapy or 
multidisciplinary rehabilitation is appropriate. Participation of patient is crucial: patient 
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wish to be taken seriously, give clear and understandable feedback during consultation, and 
discuss what can be done. 
Is needed to improve structuring of multidisciplinary and low cost consultation (Laerum E, 
2006), and indicate only surgery treatment in selected cases, by minimally invasive 
techniques. 
The other hand we must improve the procedures for developing clinical trials to make them 
consistent, and adopt the quality standards in obtaining scientific evidence; for this are 
emerging tools that help groups and conduct systematic reviews using criteria of quality, 
transparency and independence. Hope this chapter helps to achieve these objectives. 
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